Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Chubb
McKesson
Accenture
Fuji
Express Scripts
US Army
Merck
Harvard Business School

Generated: June 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 070751

« Back to Dashboard

NDA 070751 describes NALBUPHINE, which is a drug marketed by Abraxis Pharm, Abbott, Abbvie, Barr, Hospira, and Igi Labs Inc, and is included in fifteen NDAs. Additional details are available on the NALBUPHINE profile page.

The generic ingredient in NALBUPHINE is nalbuphine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the nalbuphine hydrochloride profile page.
Summary for 070751
Tradename:NALBUPHINE
Applicant:Abraxis Pharm
Ingredient:nalbuphine hydrochloride
Patents:0
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 070751

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:Jul 2, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Dow
Julphar
Argus Health
Fish and Richardson
UBS
Daiichi Sankyo
Mallinckrodt
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.